在Karen Lynch上周五迅速离职后， 西维斯健康 (CVS.US)新任首席执行官David Joyner接任首席执行官一职。华尔街分析师和一些投资者质疑，在安泰医疗保险公司 ...

Recent health news highlights include a CDC team assessing bird flu in Washington state farm workers, CVS's leadership change ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

David Joyner已成为CVS健康(NYSE:CVS)的新任CEO，在Karen Lynch上周五离职后接任。华尔街分析师和一些投资者对Joyner能否解决困扰Aetna健康保险业务的高医疗成本问题表示担忧。Joyner自2023年起负责CVS的Caremark药房福利管理业务，上周三由董事会任命。 这次领导层变动恰逢CVS撤回2024年盈利预测，并宣布第三季度利润将大幅低于分析师预期，导致 ...

As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on Friday, Wall Street ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.

As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on Friday, Wall Street ...

Pharmacies prescribe big changes, Apple and Nvidia keep tech stocks rally going, canceling subscriptions gets easier ...